BUHLMANN News – Buhlmann Diagnostics Corp

BUHLMANN News

BÜHLMANN Laboratories AG Receives FDA Clearance for its fCAL® turbo Automated Calprotectin Test

BÜHLMANN fCAL® turbo, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool, has received 510(k) ...
Read More

Check Us Out at AMLI 2019

We offer a comprehensive autoimmunity product line comprised of robust assays for simple, esoteric testing for important markers and it ...
Read More

Visit BUHLMANN at AACC 2019

 Assays Offerings: We offer a selection of unique, high-quality assays for Cellular Allergy testing such as the BÜHLMANN Flow CAST® product group  and numerous ...
Read More

Evaluation BÜHLMANN fCAL® Turbo Test – Kantonsspital St.Gallen

BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada ...
Read More

Experience with BUHLMANN fCAL turbo- SYNLAB

BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada ...
Read More

BUHLMANN fCAL turbo Customer Testimonials

View a compilation of twelve user testimonials from UK, Ireland, Switzerland and France that have been published so far for ...
Read More

Educational Webinar- Calprotectin in the Diagnosis of Inflammatory Bowel Disease

BÜHLMANN fCAL® ELISA is FDA 510(k) cleared.  For in vitro Diagnostic Use. Health Canada License: 80726 Abstract Inflammatory Bowel Disease (IBD) is ...
Read More

Basophils Are Still Alive

Quality Assay & Sample Stability for Viable Basophils Basophil Activation Testing (often referred to as BAT) is a flow-cytometry-based functional ...
Read More
Loading...